iTolerance

Be the first to hear what’s next at iTolerance.

Subscribe for email alerts and stay informed on the latest milestones, scientific progress and company developments.

Sign up: https://bit.ly/3PYFAqw

At iTolerance, our values guide everything we do, from integrity and accountability to respect and teamwork.

Together, we are committed to advancing innovation while working to improve patients’ lives.

Today, we celebrate 250 years of American independence and the freedoms that unite us.
From all of us at iTolerance, we wish you a safe, happy and meaningful Fourth of July.

Get the latest updates from iTolerance delivered directly to your inbox.
Sign up for email alerts to stay informed on company news, research progress and updates.
https://bit.ly/3PYFAqw

Innovation. Expertise. Breakthroughs.
iTolerance is a patient-first, data-driven regenerative medicine company focused on developing potential cures that improve the lives of people living with chronic conditions.

Stay up to date with the latest from iTolerance.

Sign up for email alerts to receive timely updates on company news and key developments.

https://bit.ly/3PYFAqw

Living with Type 1 Diabetes comes with real challenges that impact patients and families every day.

Our Patient Journey video series shares firsthand stories from those living with T1D and the people who support them.

Watch here: https://bit.ly/4qfl1pt

We are deeply saddened by the tragic and unexpected passing of our CEO and President, Anthony Japour. Anthony was not only a remarkable leader, but also someone whose warmth, generosity, and unwavering support left a lasting impact on all of us. Our hearts are with his family and loved ones during this incredibly difficult time. He will be deeply missed and forever remembered.